MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNA-25 (miR-25) expression is altered in various cancers, but its role in osteosarcoma is unclear.
• Osteosarcoma is a primary bone malignancy with significant metastatic potential.

Purpose of the Study:

• To investigate the role and mechanism of miR-25 in osteosarcoma progression.
• To determine if miR-25 acts as an oncogene or tumor suppressor in osteosarcoma.

Main Methods:

• Quantitative real-time PCR to assess miR-25 expression in osteosarcoma tissues and cell lines.
• In vitro assays (proliferation, colony formation, migration, invasion) and in vivo tumor growth studies.
• Bioinformatics analysis and luciferase reporter assays to identify miR-25 targets.
• Western blotting to evaluate protein expression levels.

Main Results:

• miR-25 was significantly downregulated in osteosarcoma tissues and cell lines.
• Low miR-25 expression correlated with advanced tumor-node-metastasis stage and lymph node metastasis.
• Restoring miR-25 suppressed osteosarcoma cell proliferation, colony formation, migration, and invasion in vitro, and retarded tumor growth in vivo.
• SOX4 (SRY-related high-mobility group box 4) was identified as a direct target of miR-25.
• miR-25 inhibited epithelial-mesenchymal transition (EMT) by decreasing SOX4 levels.
• miR-25 and SOX4 expression were inversely correlated in osteosarcoma tissues.
• SOX4 overexpression rescued the inhibitory effects of miR-25 on osteosarcoma cell behaviors.

Conclusions:

• miR-25 functions as a tumor suppressor in osteosarcoma progression.
• miR-25 exerts its tumor-suppressive effects by directly targeting and repressing SOX4 expression, thereby inhibiting EMT.